SEARCH

SEARCH BY CITATION

References

  • 1
    Zelefsky MJ, Eastham JA, Cronin AM et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J. Clin. Oncol. 2010; 28: 150813.
  • 2
    Kupelian PA, Potters L, Khuntia D et al. Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy ≥ 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int. J. Rad. Oncol. Biol. Phys. 2004; 58: 2533.
  • 3
    Litwin MS, Gore JL, Kwan L et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 223947.
  • 4
    Ferrer M, Suarez JF, Guedea F et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int. J. Rad. Oncol. Biol. Phys. 2008; 72: 42132.
  • 5
    Sanda MG, Dunn RL, Michalski J et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 2008; 358: 125061.
  • 6
    Namiki S, Satoh T, Baba S et al. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology 2006; 68: 12306.
  • 7
    Hashine K, Kusuhara Y, Miura N et al. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. Jpn. J. Clin. Oncol. 2009; 39: 5028.
  • 8
    Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J. Clin. Oncol. 2009; 27: 391622.
  • 9
    Pardo Y, Guedea F, Aguiló F et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J. Clin. Oncol. 2010; 28: 468796.
  • 10
    Crook JM, Gomez-Iturriaga A, Wallace K. Comparison of health-related quality of life 5 years after SPIRIT: surgical prostatectomy versus interstitial radiation intervention trial. J. Clin. Oncol. 2011; 29: 3628.
  • 11
    Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese Version. Institute for Health Outcomes and Process Evaluation Research, Kyoto, 2004.
  • 12
    Kakehi Y, Takegami M, Suzukamo Y et al. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the expanded prostate cancer index composite. J. Urol. 2007; 177: 185661.
  • 13
    Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer. Jpn. J. Clin. Oncol. 2008; 38: 4805.
  • 14
    Yoshimura K, Arai Y, Ichioka K, Matsui Y, Ogura K, Terai A. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy. Prostate Cancer Prostatic Dis. 2004; 7: 14451.
  • 15
    Tanaka N, Fujimoto K, Asakawa I et al. Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer. Brachytherapy 2010; 9: 3006.
  • 16
    Miller DC, Sanda MG, Dunn RL et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J. Clin. Oncol. 2005; 23: 277280.
  • 17
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J. Urol. 2007; 177: 21516.
  • 18
    Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J. Natl. Cancer Inst. 2009; 101: 88892.
  • 19
    Namiki S, Ichidoya S, Ito A et al. Quality of life after radical prostatectomy in Japanese men: a 5-year follow up study. Int. J. Urol. 2009; 16: 7581.